(S)-2-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)benzyl)-2H-pyran-2-carboxylic acid

ID: ALA2282522

PubChem CID: 76334424

Max Phase: Preclinical

Molecular Formula: C25H23NO5

Molecular Weight: 417.46

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1oc(-c2ccccc2)nc1CCOc1ccc(C[C@@]2(C(=O)O)C=CC=CO2)cc1

Standard InChI:  InChI=1S/C25H23NO5/c1-18-22(26-23(31-18)20-7-3-2-4-8-20)13-16-29-21-11-9-19(10-12-21)17-25(24(27)28)14-5-6-15-30-25/h2-12,14-15H,13,16-17H2,1H3,(H,27,28)/t25-/m1/s1

Standard InChI Key:  CBAPCEBKWQCANY-RUZDIDTESA-N

Molfile:  

     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   12.9134  -22.5141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1967  -22.9225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1920  -23.7428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9023  -24.1610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6190  -23.7526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6254  -22.9260    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.0576  -22.5266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0565  -23.3540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7713  -23.7669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4878  -23.3535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4849  -22.5229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7695  -22.1137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1979  -22.1077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3416  -23.7659    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6275  -23.3529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6280  -22.1043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3431  -22.5160    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.6272  -21.2792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9125  -23.7648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2528  -23.2699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2655  -22.4427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4850  -22.1754    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9896  -22.8351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4640  -23.5101    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9405  -21.9682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1645  -22.8272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7624  -22.1062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9380  -22.0980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5178  -22.8091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9280  -23.5300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7510  -23.5348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 11 13  1  0
 13  1  1  0
  8 14  1  0
 14 15  1  0
  1 16  1  1
 16 17  1  0
 16 18  2  0
 15 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 20  1  0
 21 25  1  0
 23 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
M  END

Associated Targets(Human)

PPARG Tclin PPAR alpha/gamma (197 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PPARG Tclin Peroxisome proliferator-activated receptor gamma (15191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PPARA Tclin Peroxisome proliferator-activated receptor alpha (9197 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 417.46Molecular Weight (Monoisotopic): 417.1576AlogP: 4.74#Rotatable Bonds: 8
Polar Surface Area: 81.79Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 3.55CX Basic pKa: 0.93CX LogP: 4.61CX LogD: 1.25
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.57Np Likeness Score: -0.13

References

1. Verma RK, Kumar V, Ghosh P, Wadhwa LK.  (2013)  3D-QSAR study of tyrosine and propanoic acid derivatives as PPAR/ dual agonists using CoMSIA,  22  (1): [10.1007/s00044-012-0003-4]

Source